v3.26.1
Segment Disclosures - Schedule of Selected Financial Information with Respect to Single Operating Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]            
Total revenues $ 1,157   $ 0   $ 2,240 $ 52
Less:            
Cost of sales 3,925   0   6,887 0
Research and development            
Total research and development 54,657   31,331   98,387 58,799
General and administrative 28,976   17,410   49,756 32,198
Total operating costs and expenses 87,558   48,741   155,030 90,997
Loss from operations (86,401)   (48,741)   (152,790) (90,945)
Other income, net 7,345   7,315   13,532 15,067
Net loss and comprehensive loss (79,056) $ (60,202) (41,426) $ (34,452) (139,258) (75,878)
Commercial and Development Revenue            
Segment Reporting [Line Items]            
Total revenues 1,147   0   2,216 0
License and Collaboration Revenue            
Segment Reporting [Line Items]            
Total revenues 10   0   24 52
Operating Segments [Member]            
Segment Reporting [Line Items]            
Total revenues 1,157   0   2,240 52
Less:            
Cost of sales 3,925   0   6,887 0
Research and development            
Clinical and manufacturing 50,947   26,371   90,073 49,436
Other research and development 3,710   4,960   8,314 9,363
Total research and development 54,657   31,331   98,387 58,799
General and administrative 28,976   17,410   49,756 32,198
Total operating costs and expenses 87,558   48,741   155,030 90,997
Loss from operations (86,401)   (48,741)   (152,790) (90,945)
Other income, net 7,345   7,315   13,532 15,067
Net loss and comprehensive loss (79,056)   (41,426)   (139,258) (75,878)
Operating Segments [Member] | Commercial and Development Revenue            
Segment Reporting [Line Items]            
Total revenues 1,147   0   2,216 0
Operating Segments [Member] | License and Collaboration Revenue            
Segment Reporting [Line Items]            
Total revenues $ 10   $ 0   $ 24 $ 52